Solid Tumor Market - Forecast(2019 - 2024)

Report Code: HCR 0379 Report Format: PDF + Excel Database
Solid tumors are diagnosed by the formation of a group of abnormal tissues that do not comprise of any cyst or liquid areas within. Solid tumours is classified into two types in medical terms, i.e. benign (non-cancerous) as well as malignant (cancerous) in nature. Solid tumors majorly comprise of lymphomas, carcinomas, sarcomas and melanomas; whereas, all forms of leukemias usually do not cause solid tumor formation. Hence, most of the solid tumors are treated via radiotherapy, chemotherapy and/or surgery. Chemotherapy is often utilized along with other modes of solid tumor treatment i.e. radiation and/or surgery. Globally increasing instances of solid tumors is expected to drive the demand for solid tumor market during the period of study.

 Solid Tumor Market

Geographically North America dominated solid tumor market driven by best in class infrastructure, best in industry practices and higher spending by the citizens towards healthcare expenditure. North America was followed by Europe and Asia-Pacific as second and third largest market for solid tumor market. Asia Pacific is projected to have fastest growth, owing to rapidly developing medical infrastructure, increasing medical tourism, increased spending, and increasing awareness amongst population in developing nations such as China, and India in this region.

This report identifies the global solid tumor market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to global solid tumor market.

This report segments global solid tumor market on the basis of drug and regional market as follows:
  • Solid Tumor Market research report is classified on the basis of drug. Some of the major drugs covered in this report are as follows: Avastin (bevacizumab), Afinitor (everolimus), Jevtana (cabazitaxel), Sutent (sunitinib), Tarceva (erlotinib), Taxotere (docetaxel), Zytiga (abiraterone acetate), Carboplatin, Cisplatin, Doxorubicin, Gemcitabine and Paclitaxel
  • Solid Tumor Market research report is classified on the basis of Type. Some of the major Types covered in this report are as follows: benign (non-cancerous) and malignant (cancerous)
  • This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the solid tumor market. Some of the major companies’ profiles in detail are as follows:
  • AstraZeneca plc
  • Abbott Laboratories, Inc.
  • Amgen, Inc.
  • Biogen Idec, Inc.
  • Boehringer Ingelheim GmbH.
1. Solid Tumor Market - Overview
1.1. Definitions and Scope
2. Solid Tumor Market - Executive summary
2.1. Market Revenue, Market Size and Key Trends by Company
2.2. Key Trends by type of Application
2.3. Key Trends segmented by Geography
3. Solid Tumor Market 
3.1. Comparative analysis
3.1.1. Product Benchmarking - Top 10 companies
3.1.2. Top 5 Financials Analysis
3.1.3. Market Value split by Top 10 companies
3.1.4. Patent Analysis - Top 10 companies
3.1.5. Pricing Analysis 
4. Solid Tumor Market – Startup companies Scenario Premium
4.1. Top 10 startup company Analysis by
4.1.1. Investment
4.1.2. Revenue
4.1.3. Market Shares
4.1.4. Market Size and Application Analysis
4.1.5. Venture Capital and Funding Scenario
5. Solid Tumor Market – Industry Market Entry Scenario Premium
5.1. Regulatory Framework Overview
5.2. New Business and Ease of Doing business index
5.3. Case studies of successful ventures
5.4. Customer Analysis – Top 10 companies
6. Solid Tumor Market Forces
6.1. Drivers
6.2. Constraints
6.3. Challenges
6.4. Porters five force model
6.4.1. Bargaining power of suppliers
6.4.2. Bargaining powers of customers
6.4.3. Threat of new entrants
6.4.4. Rivalry among existing players
6.4.5. Threat of substitutes 
7. Solid Tumor Market -Strategic analysis
7.1. Value chain analysis
7.2. Opportunities analysis
7.3. Product life cycle
7.4. Suppliers and distributors Market Share
8. Solid Tumor Market – By Type (Market Size -$Million / $Billion)
8.1. Market Size and Market Share Analysis 
8.2. Application Revenue and Trend Research
8.3. Product Segment Analysis
8.3.1. Benign (non-cancerous)
8.3.2. Malignant (cancerous)
9. Solid Tumor Market – By Drug (Market Size -$Million / $Billion)
9.1. Avastin (bevacizumab)
9.2. Afinitor (everolimus)
9.3. Jevtana (cabazitaxel)
9.4. Sutent (sunitinib)
9.5. Tarceva (erlotinib)
9.6. Taxotere (docetaxel)
9.7. Zytiga (abiraterone acetate)
9.8. Carboplatin
9.9. Cisplatin
9.10. Doxorubicin
9.11. Gemcitabine
9.12. Paclitaxel
10. Solid Tumor - By Geography (Market Size -$Million / $Billion)
10.1. Solid Tumor Market - North America Segment Research
10.2. North America Market Research (Million / $Billion)
10.2.1. Segment type Size and Market Size Analysis 
10.2.2. Revenue and Trends
10.2.3. Application Revenue and Trends by type of Application
10.2.4. Company Revenue and Product Analysis
10.2.5. North America Product type and Application Market Size
10.2.5.1. U.S.
10.2.5.2. Canada 
10.2.5.3. Mexico 
10.2.5.4. Rest of North America
10.3. Solid Tumor - South America Segment Research
10.4. South America Market Research (Market Size -$Million / $Billion)
10.4.1. Segment type Size and Market Size Analysis 
10.4.2. Revenue and Trends
10.4.3. Application Revenue and Trends by type of Application
10.4.4. Company Revenue and Product Analysis
10.4.5. South America Product type and Application Market Size
10.4.5.1. Brazil  
10.4.5.2. Venezuela
10.4.5.3. Argentina
10.4.5.4. Ecuador
10.4.5.5. Peru
10.4.5.6. Colombia 
10.4.5.7. Costa Rica
10.4.5.8. Rest of South America
10.5. Solid Tumor - Europe Segment Research
10.6. Europe Market Research (Market Size -$Million / $Billion)
10.6.1. Segment type Size and Market Size Analysis 
10.6.2. Revenue and Trends
10.6.3. Application Revenue and Trends by type of Application
10.6.4. Company Revenue and Product Analysis
10.6.5. Europe Segment Product type and Application Market Size
10.6.5.1. U.K  
10.6.5.2. Germany 
10.6.5.3. Italy 
10.6.5.4. France
10.6.5.5. Netherlands
10.6.5.6. Belgium
10.6.5.7. Spain
10.6.5.8. Denmark
10.6.5.9. Rest of Europe
10.7. Solid Tumor – APAC Segment Research
10.8. APAC Market Research (Market Size -$Million / $Billion)
10.8.1. Segment type Size and Market Size Analysis 
10.8.2. Revenue and Trends
10.8.3. Application Revenue and Trends by type of Application
10.8.4. Company Revenue and Product Analysis
10.8.5. APAC Segment – Product type and Application Market Size
10.8.5.1. China 
10.8.5.2. Australia
10.8.5.3. Japan 
10.8.5.4. South Korea
10.8.5.5. India
10.8.5.6. Taiwan
10.8.5.7. Malaysia
11. Solid Tumor Market - Entropy
11.1. New product launches
11.2. M&A's, collaborations, JVs and partnerships
12. Solid Tumor Market – Industry / Segment Competition landscape Premium
12.1. Market Share Analysis
12.1.1. Market Share by Country- Top companies
12.1.2. Market Share by Region- Top 10 companies
12.1.3. Market Share by type of Application – Top 10 companies
12.1.4. Market Share by type of Product / Product category- Top 10 companies
12.1.5. Market Share at global level- Top 10 companies
12.1.6. Best Practises for companies
13. Solid Tumor Market – Key Company List by Country Premium
14. Solid Tumor Market Company Analysis
14.1. Market Share, Company Revenue, Products, M&A, Developments
14.2. AstraZeneca plc
14.3. Abbott Laboratories, Inc.
14.4. Amgen, Inc.
14.5. Biogen Idec, Inc.
14.6. Boehringer Ingelheim GmbH
14.7. Baxter International, Inc.
14.8. Bristol-Myers Squibb Company
14.9. F. Hoffmann-La Roche Ltd.
14.10. Eli Lilly and Company
14.11. Johnson & Johnson
14.12. GlaxoSmithKline plc
14.13. Kyowa Hakko Kirin Co., Ltd.
14.14. Sanofi 
14.15. Company 14
14.16. Company 15
14.17. Company 16 and more
"*Financials would be provided on a best efforts basis for private companies"
15. Solid Tumor Market -Appendix
15.1. Abbreviations
15.2. Sources
16. Solid Tumor Market -Methodology Premium
16.1. Research Methodology
16.1.1. Company Expert Interviews
16.1.2. Industry Databases
16.1.3. Associations
16.1.4. Company News
16.1.5. Company Annual Reports
16.1.6. Application Trends
16.1.7. New Products and Product database
16.1.8. Company Transcripts
16.1.9. R&D Trends
16.1.10. Key Opinion Leaders Interviews
16.1.11. Supply and Demand Trends
List of Tables:

Table 1: Solid Tumor Market Overview 2019-2024
Table 2: Solid Tumor Market Leader Analysis 2018-2019 (US$)
Table 3: Solid Tumor Market Product Analysis 2018-2019 (US$)
Table 4: Solid Tumor Market End User Analysis 2018-2019 (US$)
Table 5: Solid Tumor Market Patent Analysis 2013-2018* (US$)
Table 6: Solid Tumor Market Financial Analysis 2018-2019 (US$)
Table 7: Solid Tumor Market Driver Analysis 2018-2019 (US$)
Table 8: Solid Tumor Market Challenges Analysis 2018-2019 (US$)
Table 9: Solid Tumor Market Constraint Analysis 2018-2019 (US$)
Table 10: Solid Tumor Market Supplier Bargaining Power Analysis 2018-2019 (US$)
Table 11: Solid Tumor Market Buyer Bargaining Power Analysis 2018-2019 (US$)
Table 12: Solid Tumor Market Threat of Substitutes Analysis 2018-2019 (US$)
Table 13: Solid Tumor Market Threat of New Entrants Analysis 2018-2019 (US$)
Table 14: Solid Tumor Market Degree of Competition Analysis 2018-2019 (US$)
Table 15: Solid Tumor Market Value Chain Analysis 2018-2019 (US$)
Table 16: Solid Tumor Market Pricing Analysis 2019-2024 (US$)
Table 17: Solid Tumor Market Opportunities Analysis 2019-2024 (US$)
Table 18: Solid Tumor Market Product Life Cycle Analysis 2019-2024 (US$)
Table 19: Solid Tumor Market Supplier Analysis 2018-2019 (US$)
Table 20: Solid Tumor Market Distributor Analysis 2018-2019 (US$)
Table 21: Solid Tumor Market Trend Analysis 2018-2019 (US$)
Table 22: Solid Tumor Market Size 2018 (US$)
Table 23: Solid Tumor Market Forecast Analysis 2019-2024 (US$)
Table 24: Solid Tumor Market Sales Forecast Analysis 2019-2024 (Units)
Table 25: Solid Tumor Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 26: Solid Tumor Market By Type, Revenue & Volume, By Benign (non-cancerous), 2019-2024 ($)
Table 27: Solid Tumor Market By Type, Revenue & Volume, By Malignant (cancerous), 2019-2024 ($)
Table 28: Solid Tumor Market, Revenue & Volume, By Drug, 2019-2024 ($)
Table 29: Solid Tumor Market By Drug, Revenue & Volume, By Avastin (bevacizumab), 2019-2024 ($)
Table 30: Solid Tumor Market By Drug, Revenue & Volume, By Afinitor (everolimus), 2019-2024 ($)
Table 31: Solid Tumor Market By Drug, Revenue & Volume, By Jevtana (cabazitaxel), 2019-2024 ($)
Table 32: Solid Tumor Market By Drug, Revenue & Volume, By Sutent (sunitinib), 2019-2024 ($)
Table 33: Solid Tumor Market By Drug, Revenue & Volume, By Tarceva (erlotinib), 2019-2024 ($)
Table 34: North America Solid Tumor Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 35: North America Solid Tumor Market, Revenue & Volume, By Drug, 2019-2024 ($)
Table 36: South america Solid Tumor Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 37: South america Solid Tumor Market, Revenue & Volume, By Drug, 2019-2024 ($)
Table 38: Europe Solid Tumor Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 39: Europe Solid Tumor Market, Revenue & Volume, By Drug, 2019-2024 ($)
Table 40: APAC Solid Tumor Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 41: APAC Solid Tumor Market, Revenue & Volume, By Drug, 2019-2024 ($)
Table 42: Middle East & Africa Solid Tumor Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 43: Middle East & Africa Solid Tumor Market, Revenue & Volume, By Drug, 2019-2024 ($)
Table 44: Russia Solid Tumor Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 45: Russia Solid Tumor Market, Revenue & Volume, By Drug, 2019-2024 ($)
Table 46: Israel Solid Tumor Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 47: Israel Solid Tumor Market, Revenue & Volume, By Drug, 2019-2024 ($)
Table 48: Top Companies 2018 (US$) Solid Tumor Market, Revenue & Volume
Table 49: Product Launch 2018-2019 Solid Tumor Market, Revenue & Volume
Table 50: Mergers & Acquistions 2018-2019 Solid Tumor Market, Revenue & Volume


List of Figures:

Figure 1: Overview of Solid Tumor Market 2019-2024
Figure 2: Market Share Analysis for Solid Tumor Market 2018 (US$)
Figure 3: Product Comparison in Solid Tumor Market 2018-2019 (US$)
Figure 4: End User Profile for Solid Tumor Market 2018-2019 (US$)
Figure 5: Patent Application and Grant in Solid Tumor Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Solid Tumor Market 2018-2019 (US$)
Figure 7: Market Entry Strategy in Solid Tumor Market 2018-2019
Figure 8: Ecosystem Analysis in Solid Tumor Market 2018
Figure 9: Average Selling Price in Solid Tumor Market 2019-2024
Figure 10: Top Opportunites in Solid Tumor Market 2018-2019
Figure 11: Market Life Cycle Analysis in Solid Tumor Market
Figure 12: GlobalBy Type Solid Tumor Market Revenue, 2019-2024 ($)
Figure 13: GlobalBy Drug Solid Tumor Market Revenue, 2019-2024 ($)
Figure 14: Global Solid Tumor Market - By Geography
Figure 15: Global Solid Tumor Market Value & Volume, By Geography, 2019-2024 ($) 
Figure 16: Global Solid Tumor Market CAGR, By Geography, 2019-2024 (%)
Figure 17: North America Solid Tumor Market Value & Volume, 2019-2024 ($)
Figure 18: US Solid Tumor Market Value & Volume, 2019-2024 ($)
Figure 19: US GDP and Population, 2018-2019 ($)
Figure 20: US GDP – Composition of 2018, By Sector of Origin
Figure 21: US Export and Import Value & Volume, 2018-2019 ($)
Figure 22: Canada Solid Tumor Market Value & Volume, 2019-2024 ($)
Figure 23: Canada GDP and Population, 2018-2019 ($)
Figure 24: Canada GDP – Composition of 2018, By Sector of Origin
Figure 25: Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 26: Mexico Solid Tumor Market Value & Volume, 2019-2024 ($)
Figure 27: Mexico GDP and Population, 2018-2019 ($)
Figure 28: Mexico GDP – Composition of 2018, By Sector of Origin
Figure 29: Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 30: South America Solid Tumor Market Value & Volume, 2019-2024 ($)
Figure 31: Brazil Solid Tumor Market Value & Volume, 2019-2024 ($)
Figure 32: Brazil GDP and Population, 2018-2019 ($)
Figure 33: Brazil GDP – Composition of 2018, By Sector of Origin
Figure 34: Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 35: Venezuela Solid Tumor Market Value & Volume, 2019-2024 ($)
Figure 36: Venezuela GDP and Population, 2018-2019 ($)
Figure 37: Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 38: Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 39: Argentina Solid Tumor Market Value & Volume, 2019-2024 ($)
Figure 40: Argentina GDP and Population, 2018-2019 ($)
Figure 41: Argentina GDP – Composition of 2018, By Sector of Origin
Figure 42: Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 43: Ecuador Solid Tumor Market Value & Volume, 2019-2024 ($)
Figure 44: Ecuador GDP and Population, 2018-2019 ($)
Figure 45: Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 46: Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 47: Peru Solid Tumor Market Value & Volume, 2019-2024 ($)
Figure 48: Peru GDP and Population, 2018-2019 ($)
Figure 49: Peru GDP – Composition of 2018, By Sector of Origin
Figure 50: Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 51: Colombia Solid Tumor Market Value & Volume, 2019-2024 ($)
Figure 52: Colombia GDP and Population, 2018-2019 ($)
Figure 53: Colombia GDP – Composition of 2018, By Sector of Origin
Figure 54: Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 55: Costa Rica Solid Tumor Market Value & Volume, 2019-2024 ($)
Figure 56: Costa Rica GDP and Population, 2018-2019 ($)
Figure 57: Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 58: Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 59: Europe Solid Tumor Market Value & Volume, 2019-2024 ($)
Figure 60: U.K Solid Tumor Market Value & Volume, 2019-2024 ($)
Figure 61: U.K GDP and Population, 2018-2019 ($)
Figure 62: U.K GDP – Composition of 2018, By Sector of Origin
Figure 63: U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 64: Germany Solid Tumor Market Value & Volume, 2019-2024 ($)
Figure 65: Germany GDP and Population, 2018-2019 ($)
Figure 66: Germany GDP – Composition of 2018, By Sector of Origin
Figure 67: Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 68: Italy Solid Tumor Market Value & Volume, 2019-2024 ($)
Figure 69: Italy GDP and Population, 2018-2019 ($)
Figure 70: Italy GDP – Composition of 2018, By Sector of Origin
Figure 71: Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 72: France Solid Tumor Market Value & Volume, 2019-2024 ($)
Figure 73: France GDP and Population, 2018-2019 ($)
Figure 74: France GDP – Composition of 2018, By Sector of Origin
Figure 75: France Export and Import Value & Volume, 2018-2019 ($)
Figure 76: Netherlands Solid Tumor Market Value & Volume, 2019-2024 ($)
Figure 77: Netherlands GDP and Population, 2018-2019 ($)
Figure 78: Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 79: Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 80: Belgium Solid Tumor Market Value & Volume, 2019-2024 ($)
Figure 81: Belgium GDP and Population, 2018-2019 ($)
Figure 82: Belgium GDP – Composition of 2018, By Sector of Origin
Figure 83: Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 84: Spain Solid Tumor Market Value & Volume, 2019-2024 ($)
Figure 85: Spain GDP and Population, 2018-2019 ($)
Figure 86: Spain GDP – Composition of 2018, By Sector of Origin
Figure 87: Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 88: Denmark Solid Tumor Market Value & Volume, 2019-2024 ($)
Figure 89: Denmark GDP and Population, 2018-2019 ($)
Figure 90: Denmark GDP – Composition of 2018, By Sector of Origin
Figure 91: Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 92: APAC Solid Tumor Market Value & Volume, 2019-2024 ($)
Figure 93: China Solid Tumor Market Value & Volume, 2019-2024
Figure 94: China GDP and Population, 2018-2019 ($)
Figure 95: China GDP – Composition of 2018, By Sector of Origin
Figure 96: China Export and Import Value & Volume, 2018-2019 ($) Solid Tumor Market China Export and Import Value & Volume, 2018-2019 ($)
Figure 97: Australia Solid Tumor Market Value & Volume, 2019-2024 ($)
Figure 98: Australia GDP and Population, 2018-2019 ($)
Figure 99: Australia GDP – Composition of 2018, By Sector of Origin
Figure 100: Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 101: South Korea Solid Tumor Market Value & Volume, 2019-2024 ($)
Figure 102: South Korea GDP and Population, 2018-2019 ($)
Figure 103: South Korea GDP – Composition of 2018, By Sector of Origin
Figure 104: South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 105: India Solid Tumor Market Value & Volume, 2019-2024 ($)
Figure 106: India GDP and Population, 2018-2019 ($)
Figure 107: India GDP – Composition of 2018, By Sector of Origin
Figure 108: India Export and Import Value & Volume, 2018-2019 ($)
Figure 109: Taiwan Solid Tumor Market Value & Volume, 2019-2024 ($)
Figure 110: Taiwan GDP and Population, 2018-2019 ($)
Figure 111: Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 112: Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 113: Malaysia Solid Tumor Market Value & Volume, 2019-2024 ($)
Figure 114: Malaysia GDP and Population, 2018-2019 ($)
Figure 115: Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 116: Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 117: Hong Kong Solid Tumor Market Value & Volume, 2019-2024 ($)
Figure 118: Hong Kong GDP and Population, 2018-2019 ($)
Figure 119: Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 120: Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 121: Middle East & Africa Solid Tumor Market Middle East & Africa 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 122: Russia Solid Tumor Market Value & Volume, 2019-2024 ($)
Figure 123: Russia GDP and Population, 2018-2019 ($)
Figure 124: Russia GDP – Composition of 2018, By Sector of Origin
Figure 125: Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 126: Israel Solid Tumor Market Value & Volume, 2019-2024 ($)
Figure 127: Israel GDP and Population, 2018-2019 ($)
Figure 128: Israel GDP – Composition of 2018, By Sector of Origin
Figure 129: Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 130: Entropy Share, By Strategies, 2018-2019* (%) Solid Tumor Market
Figure 131: Developments, 2018-2019* Solid Tumor Market
Figure 132: Company 1 Solid Tumor Market Net Revenue, By Years, 2018-2019* ($)
Figure 133: Company 1 Solid Tumor Market Net Revenue Share, By Business segments, 2018 (%)
Figure 134: Company 1 Solid Tumor Market Net Sales Share, By Geography, 2018 (%)
Figure 135: Company 2 Solid Tumor Market Net Revenue, By Years, 2018-2019* ($)
Figure 136: Company 2 Solid Tumor Market Net Revenue Share, By Business segments, 2018 (%)
Figure 137: Company 2 Solid Tumor Market Net Sales Share, By Geography, 2018 (%)
Figure 138: Company 3 Solid Tumor Market Net Revenue, By Years, 2018-2019* ($)
Figure 139: Company 3 Solid Tumor Market Net Revenue Share, By Business segments, 2018 (%)
Figure 140: Company 3 Solid Tumor Market Net Sales Share, By Geography, 2018 (%)
Figure 141: Company 4 Solid Tumor Market Net Revenue, By Years, 2018-2019* ($)
Figure 142: Company 4 Solid Tumor Market Net Revenue Share, By Business segments, 2018 (%)
Figure 143: Company 4 Solid Tumor Market Net Sales Share, By Geography, 2018 (%)
Figure 144: Company 5 Solid Tumor Market Net Revenue, By Years, 2018-2019* ($)
Figure 145: Company 5 Solid Tumor Market Net Revenue Share, By Business segments, 2018 (%)
Figure 146: Company 5 Solid Tumor Market Net Sales Share, By Geography, 2018 (%)
Figure 147: Company 6 Solid Tumor Market Net Revenue, By Years, 2018-2019* ($)
Figure 148: Company 6 Solid Tumor Market Net Revenue Share, By Business segments, 2018 (%)
Figure 149: Company 6 Solid Tumor Market Net Sales Share, By Geography, 2018 (%)
Figure 150: Company 7 Solid Tumor Market Net Revenue, By Years, 2018-2019* ($)
Figure 151: Company 7 Solid Tumor Market Net Revenue Share, By Business segments, 2018 (%)
Figure 152: Company 7 Solid Tumor Market Net Sales Share, By Geography, 2018 (%)
Figure 153: Company 8 Solid Tumor Market Net Revenue, By Years, 2018-2019* ($)
Figure 154: Company 8 Solid Tumor Market Net Revenue Share, By Business segments, 2018 (%)
Figure 155: Company 8 Solid Tumor Market Net Sales Share, By Geography, 2018 (%)
Figure 156: Company 9 Solid Tumor Market Net Revenue, By Years, 2018-2019* ($)
Figure 157: Company 9 Solid Tumor Market Net Revenue Share, By Business segments, 2018 (%)
Figure 158: Company 9 Solid Tumor Market Net Sales Share, By Geography, 2018 (%)
Figure 159: Company 10 Solid Tumor Market Net Revenue, By Years, 2018-2019* ($)
Figure 160: Company 10 Solid Tumor Market Net Revenue Share, By Business segments, 2018 (%)
Figure 161: Company 10 Solid Tumor Market Net Sales Share, By Geography, 2018 (%)
Figure 162: Company 11 Solid Tumor Market Net Revenue, By Years, 2018-2019* ($)
Figure 163: Company 11 Solid Tumor Market Net Revenue Share, By Business segments, 2018 (%)
Figure 164: Company 11 Solid Tumor Market Net Sales Share, By Geography, 2018 (%)
Figure 165: Company 12 Solid Tumor Market Net Revenue, By Years, 2018-2019* ($)
Figure 166: Company 12 Solid Tumor Market Net Revenue Share, By Business segments, 2018 (%)
Figure 167: Company 12 Solid Tumor Market Net Sales Share, By Geography, 2018 (%)
Figure 168: Company 13 Solid Tumor Market Net Revenue, By Years, 2018-2019* ($)
Figure 169: Company 13 Solid Tumor Market Net Revenue Share, By Business segments, 2018 (%)
Figure 170: Company 13 Solid Tumor Market Net Sales Share, By Geography, 2018 (%)
Figure 171: Company 14 Solid Tumor Market Net Revenue, By Years, 2018-2019* ($)
Figure 172: Company 14 Solid Tumor Market Net Revenue Share, By Business segments, 2018 (%)
Figure 173: Company 14 Solid Tumor Market Net Sales Share, By Geography, 2018 (%)
Figure 174: Company 15 Solid Tumor Market Net Revenue, By Years, 2018-2019* ($)
Figure 175: Company 15 Solid Tumor Market Net Revenue Share, By Business segments, 2018 (%)
Figure 176: Company 15 Solid Tumor Market Net Sales Share, By Geography, 2018 (%)